Abstract
We evaluated the longitudinal dynamics of antibody response to the SARS-CoV-2 vaccine CoronaVac and the effect of a booster dose of BNT162b2 vaccine. We found a robust antibody response after the second dose of CoronaVac that wanes over time. The response was recovered by BNT162b2, which boosted anti-spike antibody titers.
Keywords: BNT162b2 vaccine; COVID-19; CoronaVac; SARS-CoV-2; antibody response; coronavirus disease; healthcare workers; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses.
All Keywords
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, BNT162b2 vaccine, Healthcare workers, Antibody Response, CoronaVac, vaccine-preventable diseases, 【초록키워드】 zoonoses, Vaccine, coronavirus, antibody, BNT162b2, healthcare, booster dose, anti-spike antibody, acute respiratory syndrome, second dose, robust, evaluated, of BNT162b2, the SARS-CoV-2, 【제목키워드】 Dynamics, response, of BNT162b2,
【저자키워드】 COVID-19, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, BNT162b2 vaccine, Healthcare workers, Antibody Response, CoronaVac, vaccine-preventable diseases, 【초록키워드】 zoonoses, Vaccine, coronavirus, antibody, BNT162b2, healthcare, booster dose, anti-spike antibody, acute respiratory syndrome, second dose, robust, evaluated, of BNT162b2, the SARS-CoV-2, 【제목키워드】 Dynamics, response, of BNT162b2,
{{{ 추상적인 }}}
우리는 SARS-CoV-2 백신 CoronaVac에 대한 항체 반응의 종단 역학과 BNT162b2 백신의 추가 용량의 효과를 평가했습니다. 우리는 시간이 지남에 따라 약해지는 CoronaVac의 두 번째 투여 후 강력한 항체 반응을 발견했습니다. 반응은 BNT162b2에 의해 회복되었으며, 이는 스파이크 방지 항체 역가를 증가시켰습니다.
{{ 키워드: }} BNT162b2 백신; 코로나바이러스감염증-19 : 코로나19; 코로나백; 사스 코로나바이러스 2; 항체 반응; 코로나바이러스 질환; 의료 종사자; 호흡기 감염; 중증 급성 호흡기 증후군 코로나바이러스 2; 백신으로 예방 가능한 질병; 바이러스; 인수공통전염병